CVRx (NASDAQ: CVRX) CFO gets major option, RSU grants and tax sale

Rhea-AI Filing Summary

CVRx, Inc. chief financial officer Jared Oasheim reported a mix of equity grants and a small mandated share sale. He received a grant of 91,000 stock options at an exercise price of $0.0000 per share, vesting 25% on February 27, 2027 and then monthly thereafter. He was also granted 61,000 shares of common stock in the form of restricted stock units that vest 25% on each annual anniversary of the grant date. To cover tax withholding obligations from these awards, he sold 1,744 shares of common stock in an open-market sell-to-cover transaction on March 2, 2026 at a weighted-average price of $7.9022 per share, with individual sale prices ranging from $7.90 to $7.9831. After these transactions, he directly held 96,703 shares of common stock.

Insider Trade Summary

Net Seller: 1,744 shares ($13,781)

Net Sell 3 txns

Insider OASHEIM JARED

Role CHIEF FINANCIAL OFFICER

Sold 1,744 shs ($14K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,744	$7.9022	$14K
Grant/Award	Stock Option (right to buy)	91,000	$0.00	--
Grant/Award	Common Stock	61,000	$0.00	--

Holdings After Transaction: Common Stock — 96,703 shares (Direct); Stock Option (right to buy) — 91,000 shares (Direct)

Footnotes (1)

1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction. Reflects the weighted average price of 1,744 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.9831 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OASHEIM JARED

(Last) (First) (Middle)

9201 W BROADWAY AVE

#650

(Street)

MINNEAPOLIS MN 55445

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		61,000(1)	A	$0	98,447	D
Common Stock	03/02/2026		S(2)		1,744	D	$7.9022(3)	96,703	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.16	02/27/2026		A		91,000		(4)	02/26/2036	Common Stock	91,000	$0	91,000	D

Explanation of Responses:

1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

2. The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

3. Reflects the weighted average price of 1,744 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.9831 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

	/s/ Amy C. Seidel, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did CVRX CFO Jared Oasheim report on this Form 4?

Jared Oasheim reported receiving 91,000 stock options and 61,000 restricted stock units, plus selling 1,744 common shares. The sale was a mandated sell-to-cover transaction to satisfy tax withholding obligations arising from the equity awards, rather than a discretionary share sale.

How many CVRX shares did the CFO sell and at what price range?

The CFO sold 1,744 shares of CVRx common stock. The weighted-average sale price was $7.9022 per share, with individual transaction prices ranging from $7.90 to $7.9831, all executed on March 2, 2026 in an open-market sell-to-cover transaction.

Were the CVRX CFO’s share sales discretionary or for tax withholding?

The reported sale was not discretionary; it was mandated by the issuer’s award agreement. The 1,744 shares were sold in a sell-to-cover transaction specifically to satisfy tax withholding obligations triggered by the new stock option and restricted stock unit grants.

What stock option grant did the CVRX CFO receive according to this filing?

He received 91,000 stock options with an exercise price of $0.0000 per share. These options vest as to 25% of the shares on February 27, 2027, with the remaining shares vesting in equal monthly installments over the following 36 months.

What restricted stock unit (RSU) award did the CVRX CFO report?

The filing shows a grant of 61,000 shares of common stock in the form of restricted stock units. These RSUs vest as to 25% of the shares on each annual anniversary of the grant date, creating a four-year vesting schedule tied to continued service.

How many CVRX common shares does the CFO hold after these transactions?

After the reported transactions, the CFO directly held 96,703 shares of CVRx common stock. This figure reflects his ownership following the equity grants and the 1,744-share sell-to-cover transaction executed to meet tax withholding obligations related to those awards.